Experienced in Selective Deficiency of IgA

Tomohisa Takagi

Kyoto, JP 
Experienced in Selective Deficiency of IgA
Kyoto, JP 
OverviewLocationsClinical Research

Overview

Tomohisa Takagi practices in Kyoto, Japan. Takagi is rated as an Experienced expert by MediFind in the treatment of Selective Deficiency of IgA. Their top areas of expertise are Colitis, Viral Gastroenteritis, Ulcerative Colitis, Endoscopy, and Colonoscopy.

Their clinical research consists of co-authoring 253 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Selective Deficiency of IgA.

Locations

Kyoto, 6028566, Japan
Other Locations
Bunkyo, Japan
Nishinomiya-hama, Japan
Bunkyo, 9108507, Japan
Tsu, 5148507, Japan
Nagoya, 4668550, Japan
Gifu-shi, 5011196, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3

253 Total Publications

Kyoto Classification-Based Predictive Factors Associated with the Development of Gastric Cancer After Helicobacter pylori Eradication: A Prospective Multicenter Observational Study.
Kyoto Classification-Based Predictive Factors Associated with the Development of Gastric Cancer After Helicobacter pylori Eradication: A Prospective Multicenter Observational Study.
Journal: Diagnostics (Basel, Switzerland)
Published: July 24, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Takagi's expertise for a condition
ConditionClose
View All 31 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile